Kev piav qhia
Peb Omeprazole intermediate 2.3.5-Trimethyl-4-nitropyridine-N-oxide yog ua tib zoo tsim kom tau raws li cov qauv kev lag luam siab tshaj plaws, ua kom nws purity thiab ua tau zoo thiab tuaj yeem siv ntau yam tshuaj thiab tshuaj.Nrog nws cov muaj pes tsawg leeg thiab tshwj xeeb zoo, qhov sib xyaw no yog qhov kev xaiv zoo tshaj plaws rau cov kws tshawb fawb, kws tshawb fawb thiab kws kho mob nrhiav kev txhim khu kev qha, kev ua haujlwm siab rau lawv cov haujlwm.
Qhov nruab nrab no ua lub luag haujlwm tseem ceeb hauv kev tsim cov omeprazole, cov tshuaj siv dav siv los kho cov kab mob acid xws li kab mob gastroesophageal reflux (GERD), peptic ulcers, thiab zolin (Tus Saib Xyuas-Ellison syndrome).Raws li cov khoom tseem ceeb hauv kev sib txuas ntawm omeprazole, peb cov omeprazole intermediate 2.3.5-trimethyl-4-nitropyridine-N-oxide pab txhawb kev tsim khoom ntawm cov tshuaj tseem ceeb thiab cov nqi tsim nyog.
Xaiv Peb
JDK muaj cov chaw tsim khoom thawj zaug thiab cov cuab yeej tswj kev ua haujlwm zoo, uas ua kom muaj kev ruaj khov ntawm API intermediates.Pab neeg tshaj lij paub tseeb R & D ntawm cov khoom.Tawm tsam ob qho tib si, peb tab tom nrhiav rau CMO & CDMO hauv kev lag luam hauv tsev thiab thoob ntiaj teb.